Svetlana Bezukladova
Milan, 20129, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.
Journal: Science translational medicine
Published: January 21, 2026
Potency assays and biomarkers for cell-based advanced therapy medicinal products.
Journal: Frontiers in immunology
Published: March 14, 2023
Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells.
Journal: Journal of virology
Published: September 19, 2022
Promoting exogenous repair in multiple sclerosis: myelin regeneration.
Journal: Current opinion in neurology
Published: June 08, 2022
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
Journal: Multiple sclerosis and related disorders
Published: October 13, 2020
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Journal: Multiple sclerosis and related disorders
Published: September 24, 2020
High serum neurofilament associates with diffuse white matter damage in MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 08, 2020
Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026